Breaking News on Pharmaceutical Technology

Latest news headlines

Products

Suppliers

Northwestern researchers find route to single-isomer flavonoids

19-Apr-2007 - A research team at Northwestern University in Illinois, US, has found a new way of synthesising chiral forms of flavonoids that could make them easier to manufacture and enhance their potential as therapeutic compounds against cancer and other diseases.

Gelatine-based vectors offer smoother passage for gene therapy

19-Apr-2007 - Gelatine-based nanoparticles may offer a new delivery route for gene therapy that skirts the complications of viral-based vectors.

First customer for USP's ingredient verification service

18-Apr-2007 - The Pharmaceutical Ingredient Verification Program offered by the United States Pharmacopeia (USP) has scored its first taker, with Indian firm Dr Reddy's Laboratories yesterday announcing that it had signed up to the scheme.

Excipient aims to improve cancer treatment

18-Apr-2007 - Pro-Pharmaceuticals is preparing to submit a New Drug Application (NDA) for its lead product candidate, Davanat, as a functional excipient that promises to hike the efficacy and cut the side effects of cancer drugs.

LibraGen's new active molecules hit the market

18-Apr-2007 - French bioprocess specialist LibraGen has released its first family of active molecules produced using the firm's biocatalysis technology onto the market.

Sanofi ups production capacity after vaccine go-ahead

18-Apr-2007 - Reports of a €200m expansion at Sanofi Pasteur's production plant in Rouen, France, have come hot on the heels of news that the US Food and Drug Administration (FDA) has approved the company's vaccine to protect humans against bird flu.

Skye formulation accepted for GSK drug

16-Apr-2007 - UK firm SkyePharma last week announced that the US Food and Drug Administration (FDA) has accepted a filing for the extended release formulation of partner GlaxoSmithKline's (GSK) drug Requip (ropinirole).

Caterpillar cells to churn out flu vaccine

11-Apr-2007 - An experimental flu vaccine produced in insect cells could be a potential money-saver for pharma firms, and has proved just as effective as vaccines produced using conventional egg-based techniques.

Spanish group finds recyclable medium for thioether derivatives

05-Apr-2007 - A group of researchers at the University of the Basque Country in Spain has developed a method of synthesising thioether derivatives using a cheap, non-toxic and recyclable medium that could have significant cost and efficiency implications for the manufacture of some pharmaceuticals.

Ajinomoto launches stable dipeptide

04-Apr-2007 - US-based Ajinomoto Aminoscience has launched AminoStable, an L-Alanyl-L-Glutamine dipeptide for use in pharmaceutical products and cell culture media.

Adams taps into MonoSol's fast-dissolve technology

03-Apr-2007 - A thin-film delivery system that looks like a postage stamp and dissolves rapidly on the tongue could give new momentum to Adams Respiratory Therapeutics' portfolio of prescription and over-the-counter medicines (OTC) for the treatment of respiratory disorders.

Have your say: New excipient GMP regs

02-Apr-2007 - Excipient manufacturers and users are being encouraged to take part in an online consultation set up by the European Commission to assess the impact of kicking off formal good manufacturing practice (GMP) regulations for excipient production.

Turning over a new leaf with cellulose drug delivery

28-Mar-2007 - A new cellulose-based drug delivery system could be on the horizon, according to a research team presenting their work this week in the US.

Kyowa Hakko to raise European amino acid prices

28-Mar-2007 - Kyowa Hakko Europe is to increase prices across its range of L-amino acids by ten per cent as of April 1, in an effort to stave off margin deterioration and ensure long-term availability of the ingredients.

DMF for ScinoPharm's docetaxel

26-Mar-2007 - Active pharmaceutical ingredient (API) specialist ScinoPharm has been assigned a drug master file (DMF) number for its anti-cancer ingredient docetaxel, the first such designation for the API in the US.

Scripps researchers free natural product synthesis from the protection racket

26-Mar-2007 - New findings from The Scripps Research Institute in the US have challenged the conventional wisdom that protecting groups are a wearying yet unavoidable rung on the ladder to natural product synthesis.

New wheat variety aids fight against blight

21-Mar-2007 - Researchers have created a new strain of wheat with an inbuilt resistance to devastating scab blight which infects wheat heads - reducing crop yields as well as market value and quality.

Fuji gets DMF for fast dissolving excipient

14-Mar-2007 - Japanese firm Fuji Chemical has been assigned a drug master file (DMF) number for its new excipient for fast-dissolving oral tablets.

Shire looking to buy more US biomanufacturing space

13-Mar-2007 - With a new drug on the market and its Massachusetts plant at capacity, British drug maker Shire is actively looking to buy more biomanufacturing space in the US.

Industry project aims to cut animal testing of excipients

12-Mar-2007 - 10 major pharmaceutical companies are taking part in an international data-sharing initiative to drive down the need for animal testing.

UK to pull pseudoephedrine

12-Mar-2007 - Drugs containing pseudoephedrine and ephedrine could soon be reclassified as prescription-only the UK, in proposals drawn up last week by the Medicines and Healthcare Products Regulatory Agency (MHRA).

Stellar results H&R Wasag pharma unit

08-Mar-2007 - Operating profit has almost quadrupled at H&R Wasag's chemical-pharmaceutical raw materials division over 2006, hitting €82.4m for the year.

Liposome technology to help DNAi-based cancer drug delivery

07-Mar-2007 - Biotech company ProNAi Therapeutics plans to use a new liposome technology to help deliver its new class of DNA interference (DNAi)-based drug.

New vaccine technology holds double promise

05-Mar-2007 - A new nanotechnology-based vaccine delivery method could allow the development of single-dose vaccines as well as new vaccines in disease areas of unmet need.

Ajinomoto ups L-Arginine price

27-Feb-2007 - Amino acid manufacturer Ajinomoto Aminoscience announced that increasing raw material and energy costs have driven the company to increase prices of its L-Arginine products by $1/ kg (€0.76/kg).

Sign up for your free newsletter